Cork, Ireland – Mar 7, 2011 – Radisens Diagnostics has been shortlisted as one of four innovative diagnostic companies to speak at the upcoming NHS Opening Doors Conference. With it’s focus on ‘Diagnostics in the Community’, the conference concentrates on Point of Care (PoC) solutions which deliver direct quality, innovation, productivity and prevention improvements.

Radisens will outline the work it’s currently doing with the NHS to deliver on their PoC requirements for the annual review of chronic care patients. Radisens unique approach allows GP’s and primary care nurses to monitor multiple diseases and blood ailments from a drop of patients blood within 15 minutes.

About Radisens Diagnostics
Radisens Diagnostics develops disruptive point-of-care diagnostic platforms and multiplexed test panels, which diagnose and monitor patients for multiple chronic and acute care conditions. This is the only point-of-care platform to integrate immunoassay, biochemistry and cellular haematology onto a single test panel. Using a finger-prick of blood, the analyser returns laboratory-grade results in the doctor’s office within minutes. With offices in Cork, Ireland and Boston, Massachusetts, Radisens Diagnostics is a convergence of medical diagnostics and consumer electronics using disruptive patent pending technology to deliver on the significant market and clinical need for decentralising diagnostics into point of care settings such as doctor’s offices, outpatient and emergency room departments, intensive care units and hospital bedsides.

Commercial Contact:
E: info @ radisens.com
T: +353 21 4868190 / Fax: +353 21 4928909